Sequential Immunization With Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine in Health Adults Based on 3 Doses Inactivated COVID-19 Vaccine

NCT05373030 · clinicaltrials.gov ↗

PHASE4

Phase

UNKNOWN

Status

200

Enrollment

OTHER_GOV

Sponsor class

Conditions

Immunogenicity and Safety of a Recombinant Adenovirus Type-5-vectored COVID-19 Vaccine Using for Sequential Immunization

Interventions

BIOLOGICAL: Recombinant adenovirus type-5-vectored COVID-19 vaccine

Sponsor

Zhejiang Provincial Center for Disease Control and Prevention